TY - JOUR
T1 - Molecular mechanisms of endothelial hyperpermeability
T2 - Implications in inflammation
AU - Kumar, Puneet
AU - Shen, Qiang
AU - Pivetti, Christopher D.
AU - Lee, Eugene S
AU - Wu, MacK H.
AU - Yuan, Sarah Y.
PY - 2009/12
Y1 - 2009/12
N2 - Endothelial hyperpermeability is a significant problem in vascular inflammation associated with trauma, ischaemia-reperfusion injury, sepsis, adult respiratory distress syndrome, diabetes, thrombosis and cancer. An important mechanism underlying this process is increased paracellular leakage of plasma fluid and protein. Inflammatory stimuli such as histamine, thrombin, vascular endothelial growth factor and activated neutrophils can cause dissociation of cell-cell junctions between endothelial cells as well as cytoskeleton contraction, leading to a widened intercellular space that facilitates transendothelial flux. Such structural changes initiate with agonist-receptor binding, followed by activation of intracellular signalling molecules including calcium, protein kinase C, tyrosine kinases, myosin light chain kinase, and small Rho-GTPases; these kinases and GTPases then phosphorylate or alter the conformation of different subcellular components that control cell-cell adhesion, resulting in paracellular hypermeability. Targeting key signalling molecules that mediate endothelial-junction-cytoskeleton dissociation demonstrates a therapeutic potential to improve vascular barrier function during inflammatory injury.
AB - Endothelial hyperpermeability is a significant problem in vascular inflammation associated with trauma, ischaemia-reperfusion injury, sepsis, adult respiratory distress syndrome, diabetes, thrombosis and cancer. An important mechanism underlying this process is increased paracellular leakage of plasma fluid and protein. Inflammatory stimuli such as histamine, thrombin, vascular endothelial growth factor and activated neutrophils can cause dissociation of cell-cell junctions between endothelial cells as well as cytoskeleton contraction, leading to a widened intercellular space that facilitates transendothelial flux. Such structural changes initiate with agonist-receptor binding, followed by activation of intracellular signalling molecules including calcium, protein kinase C, tyrosine kinases, myosin light chain kinase, and small Rho-GTPases; these kinases and GTPases then phosphorylate or alter the conformation of different subcellular components that control cell-cell adhesion, resulting in paracellular hypermeability. Targeting key signalling molecules that mediate endothelial-junction-cytoskeleton dissociation demonstrates a therapeutic potential to improve vascular barrier function during inflammatory injury.
UR - http://www.scopus.com/inward/record.url?scp=69149101976&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=69149101976&partnerID=8YFLogxK
U2 - 10.1017/S1462399409001112
DO - 10.1017/S1462399409001112
M3 - Article
C2 - 19563700
AN - SCOPUS:69149101976
VL - 11
JO - Expert Reviews in Molecular Medicine
JF - Expert Reviews in Molecular Medicine
SN - 1462-3994
M1 - e19
ER -